Skip to content
OpenCapital
Get started

InfuSystem Holdings INFU Device Solutions — Gross Profit

Other segment segments

Patient Services
$14.32M+8.6%

Similar metrics at other companies

Aveanna Healthcare Holdings Inc. logo
AVAHMedical Solutions — Gross Profit
$20.42M+12.6%
Novanta logo
NOVTMedical Solutions — Gross Profit
$52.18M+13.5%
Itron logo
ITRIDevice Solutions — Revenue
$124.38M-1.2%
Itron logo
ITRIDevice Solutions — Adjusted segment operating income (loss)
$36.89M+21.1%
Neuronetics logo
STIMMedical Device — Gross Profit
$10.07M-1.0%
CSP logo
CSPITechnology Solutions — Gross Profit
$4.3M+12.1%

Other financials

Income statement

See full
Revenue$33.7M-3.0%
Gross profit$19.7M+2.7%
Operating income$1.6M+157%
Net income$1.0M+481%
EPS (diluted)$0.05+600%

Balance sheet

See full
Cash & equivalents$2.1M+39.8%
Total debt$24.1M-30.4%
Total equity$58.7M+6.5%
Total assets$98.7M-5.4%

Cash flow

See full
Operating cash flow$970.0K-45.5%
CapEx$157.0K+19.8%
Free cash flow$813.0K-50.7%

Valuation

See full
Market cap$205.05M+51.3%
Enterprise value$227.04M+36.2%
P/E25.9×-0.8×
P/S1.4×+0.5×

Profitability

See full
Gross margin56.7%+3.6pp
Operating margin9.1%+3.0pp
Net margin5.6%+3.2pp
FCF margin16.2%+1.0pp

Returns & leverage

See full
Return on equity13.9%+8.0pp
Debt / equity0.4×-0.2×
Current ratio2.1×-0.1×

Where this comes from

Reported directly by InfuSystem Holdings in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: InfuSystem Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about InfuSystem Holdings's device solutions — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is InfuSystem Holdings's device solutions — gross profit?
InfuSystem Holdings (INFU) reported device solutions — gross profit of $5.36M in Q1 2026.
How has InfuSystem Holdings's device solutions — gross profit changed year-over-year?
InfuSystem Holdings's device solutions — gross profit decreased by 10.4% year-over-year, from $5.98M to $5.36M.
What is the long-term trend for InfuSystem Holdings's device solutions — gross profit?
Over 4 years (2021 to 2025), InfuSystem Holdings's device solutions — gross profit has grown at a 10.9% compound annual growth rate (CAGR), from $16.49M to $24.92M.
What does device solutions — gross profit mean?
Calculated as the total revenue generated by the Device Solutions segment minus the direct costs associated with providing those services and products. This metric serves as a primary indicator of the segment's pricing power and its ability to manage direct production or service delivery costs. A higher gross profit margin suggests efficient operational execution and strong value proposition within the medical equipment market.